comparemela.com

Latest Breaking News On - Iterum therapeutics - Page 2 : comparemela.com

ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024

ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Iterum Therapeutics (NASDAQ:ITRM) Stock Rating Reaffirmed by HC Wainwright

Iterum Therapeutics (NASDAQ:ITRM) Stock Rating Reaffirmed by HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Iterum Therapeutics (NASDAQ:ITRM) Stock Rating Reaffirmed by HC Wainwright

Iterum Therapeutics (NASDAQ:ITRM – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued on Tuesday, Benzinga reports. They presently have a $6.00 price objective on the stock. HC Wainwright’s target price points to a potential upside of 277.36% from the stock’s current price. Iterum […]

Iterum Therapeutics Plc (ITRM) Resubmits NDA for Oral Sulopenem

Iterum Therapeutics Plc (ITRM) Resubmits NDA for Oral Sulopenem
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Head to Head Analysis: Iterum Therapeutics (NASDAQ:ITRM) & RedHill Biopharma (NASDAQ:RDHL)

RedHill Biopharma (NASDAQ:RDHL – Get Free Report) and Iterum Therapeutics (NASDAQ:ITRM – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations. Risk and Volatility RedHill Biopharma has a […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.